Caplin Point Laboratories Ltd

NSE: CAPLIPOINT · BSE: 524742 · Pharmaceuticals & Biotechnology · 12 announcements

Share price

₹2,835.10

Market cap

₹21,550 Cr

Revenue (annual)

₹2,187 Cr

Net profit (annual)

₹641.2 Cr

P/E (TTM)

32.4×Sector 50.4×

Promoter holding

70.57%+0.00% QoQ

FII holding

5.76%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.